Get the content you want anytime you want.
REGISTER NOW | SIGN IN

Society of Infectious Diseases Pharmacists

Society of Infectious Diseases Pharmacists
Founded in 1990, the Society of Infectious Diseases Pharmacists (SIDP) is an association of pharmacists and allied healthcare professionals dedicated to promoting the appropriate use of antimicrobial agents.

Latest Partner Content

Are Narrow-Spectrum Antibiotics More Effective Against <i>C. difficile</i>?
Kirk Hevener, PharmD, PhD, explains why narrow-spectrum antibiotics are more beneficial for treating C. difficile.
What Is the Importance of Antimicrobial Susceptibility Testing for Off-Label Indications?
Jason Gallagher, PharmD, BCPS, FCCP, FIDSA, explains the importance of antimicrobial susceptibility testing for off-label indications.
Lack of Benefit of Azithromycin Use in Acute Asthma Exacerbations
Recent research shows no clinical benefits from adding azithromycin to standard treatment for adults who presented to emergency departments with acute asthma exacerbations requiring a corticosteroid course.
Why is Antimicrobial Susceptibility Testing a Key Player in Stewardship Programs?
James S. Lewis, PharmD, FIDSA, explains why antimicrobial susceptibility testing is so important when it comes to stewardship programs.
Why is Multidrug-Resistant <i>Pseudomonas aeruginosa</i> a Priority Pathogen?
Jason Pogue, PharmD, BCPS-ID, Clinical Pharmacist, Infectious Diseases, Sinai-Grace Hospital, explains why Pseudomonas aeruginosa is one of the World Health Organization’s critical priority pathogens for new research and development priorities.
What Are The Drawbacks Of Current Front-Line Drugs to Treat <i>C. difficile</i> Infection?
Kirk Hevener, PharmD, PhD, explains the drawbacks of first-line drugs that are currently used to treat C. difficile infections.
How Are Antimicrobial Stewardship Programs Lacking in Long-term Care Facilities?
Alan Gross, PharmD, BCPS-AQID, explains how antimicrobial stewardship programs need to be strengthened in long-term care facilities.
Incentivizing Antibiotic Drug Development to Address Antimicrobial Resistance
Researchers describe how government and pharmaceutical companies develop are working to develop new drugs for emerging infectious diseases.
FEATURED
Big advances in treatment can